Tipping the balance - improving response rates to cancer immunotherapy [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Survival rates for some types of cancer remain low. It was previously thought that chemotherapy could not be combined with drugs that affect the immune system (immunotherapy) to treat cancer. My research disproved this. I develop models to study cancer in the lab. I also research ways to measure how people’s bodies respond to chemotherapy and immunotherapy (biomarkers). I use this information to discover new drug combinations to reduce deaths from cancer.

Funding Amount $1,562,250

Funding Scheme Investigator Grants

Chief Investigator Dr Willem Lesterhuis

Notes Emerging Leadership 2